Hardik Shah(@AIStockSavvy):$MRNA | Bernstein SocGen Group 𝗿𝗲𝗶𝘁𝗲𝗿𝗮𝘁𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝗣𝗲𝗿𝗳𝗼𝗿𝗺 on 𝗠𝗼𝗱𝗲𝗿𝗻𝗮, maintains PT at $𝟰𝟱 Analyst sees Intismeran as the clearest mRNA platform validation, with expansion now the key question.

Hardik Shah

@AIStockSavvy

Software Developer | AI-Powered News Insights, Earnings Reports and Analyst Ratings | Follow for Savvy Insights, Not Advice #AI# #StockMarket#

가입 September 2009

1.2K 팔로잉 중 41.1K 팬

Hardik Shah@AIStockSavvy

2026.09.25 12:11

$MRNA | Bernstein SocGen Group 𝗿𝗲𝗶𝘁𝗲𝗿𝗮𝘁𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝗣𝗲𝗿𝗳𝗼𝗿𝗺 on 𝗠𝗼𝗱𝗲𝗿𝗻𝗮, maintains PT at $𝟰𝟱 Analyst sees Intismeran as the clearest mRNA platform validation, with expansion now the key question.